Device Trial Radar · NCT00735722
A(f)MAZE-CABG Study
Last checked: Nov 19, 2026Latest source record: Feb 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
188
Actual
Start
Jul 2009
Primary completion
Aug 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Aug 15, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Concomitant AF ablation with HIFU in patients with persistent or long standing persistent AF undergoing CABG will be superior in restoring SR, compared with patients with persistent or long standing persistent AF undergoing CABG treated with best medical treatment according to ACC/AHA/ESC 2006 guidelines and no AF ablation.
Conditions
- Coronary Arteriosclerosis
- Atrial Fibrillation
- Coronary Artery Bypass Graft Surgery
Interventions
HIFU AF AblationDevice
Concomitant left atrial ablation using High Intensity Focused Ultrasound (HIFU)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from Atrial Arrhythmias (AF, Atrial Flutter, Atrial Tachycardia) at 12 monthsTime frame: 12 months
Locations
10 sites in 6 countries. Site status is shown where the registry gives one.
Queen Elisabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Tampere University Hospital
Tampere, Western Finland, Finland
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.